🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
First-line antiretroviral regimens are highly efficacious and generally wel...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-06
Trial ID
NCT03682848
Treatments Being Tested
HIV Treatment simplification strategies that involve switching cART regimen...
Status
Unknown
Location
Hôpital de Bicêtre
Start Date
2021-04-12
Trial ID
NCT04788784
Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patie...
Status
Completed
Location
Fundación Huésped
Start Date
2021-05-17
Trial ID
NCT04880395
In people infected with HIV, with suppressed HIV viral load and receiving t...
Status
Completed
Location
H. Universitario Son Espases
Start Date
2022-10-06
Trial ID
NCT05549180
Long-term side effects of antiretrovirals (ART) have led to the introductio...
Status
Completed
Location
University Hospital of Modena- Infetious Diseases Clinic
Start Date
2020-01-23
Trial ID
NCT04054089
The goal of this clinical trial is to determine the efficacy of Dolutegravi...
Status
Not Yet Recruiting
Location
Saskatchewan Health Authority
Start Date
2024-09-30
Trial ID
NCT06580873
Treatments Being Tested
The aim of this study is to monitor virological and immunological markers i...
Status
Recruiting
Location
Ghent University Hospital
Start Date
2020-05-26
Trial ID
NCT04553081
Treatments Being Tested
This clinical study is testing a new medication, VH4524184, to see if it ca...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2026-02-11
Trial ID
NCT07202546
This is a multicentre study carried out in participants living with human i...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-07-06
Trial ID
NCT05917509
Treatments Being Tested